HHLR ADVISORS, LTD.
Institutional investor · Portfolio as of Q3 2025
Top Holdings33 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
PDD HOLDINGS INC | 8.6M | $1.1B | 27.8% | $114.21 | +14.41% | 14 qtrssince 2022-Q2 | Increased 76 |
ALIBABA GROUP HOLDING-SP ADR | 3.3M | $588M | 14.4% | $144.42 | +22.63% | 14 qtrssince 2022-Q2 | Increased 100 |
FUTU HLDGS LTD | 3.2M | $563.2M | 13.8% | $95.17 | +82.47% | 6 qtrssince 2024-Q2 | Decreased 0 |
WEBULL CORP | 33.1M | $489.3M | 12.0% | $10.83 | +43.58% | 2 qtrssince 2025-Q2 | Unchanged 0 |
BEIGENE LTD-ADR | 1M | $352.4M | 8.6% | $134.02 | +148.34% | 28 qtrssince 2018-Q4 | Unchanged 0 |
BAIDU INC - SPON ADR | 1.6M | $216.2M | 5.3% | $134.86 | -22.79% | 1 qtr | New 96 |
Legend Biotech Corp. Sponsored ADR | 6M | $195.2M | 4.8% | $50.33 | -34.73% | 22 qtrssince 2020-Q2 | Unchanged 0 |
NETEASE INC-ADR | 790,807 | $120.2M | 2.9% | $90.38 | +66.79% | 12 qtrssince 2022-Q4 | Decreased 0 |
ARRIVENT BIOPHARMA INC | 4.5M | $82.7M | 2.0% | $17.95 | +1.20% | 7 qtrssince 2024-Q1 | Unchanged 0 |
KE HOLDINGS INC-ADR | 4.2M | $80.5M | 2.0% | $21.74 | -7.03% | 21 qtrssince 2020-Q3 | Decreased 0 |
FULL TRUCK ALLIANCE CO LTD | 4.1M | $52.7M | 1.3% | $13.08 | -32.42% | 1 qtr | New 68 |
YATSEN HLDG LTD | 4.9M | $44.3M | 1.1% | $10.59 | -12.10% | 20 qtrssince 2020-Q4 | Decreased 0 |
SEA LTD-ADR | 180,050 | $32.2M | 0.8% | $181.45 | -34.17% | 1 qtr | New 57 |
CLEARWATER ANALYTICS HDS-A | 1.4M | $24.6M | 0.6% | $22.00 | -17.27% | 2 qtrssince 2025-Q2 | Unchanged 0 |
CYTEK BIOSCIENCES INC | 6.7M | $23.1M | 0.6% | $20.96 | -83.87% | 17 qtrssince 2021-Q3 | Unchanged 0 |
NOVABRIDGE BIOSCIENCES | 6M | $22.6M | 0.6% | $47.24 | -92.76% | 21 qtrssince 2020-Q3 | Unchanged 0 |
GOSSAMER BIO INC | 5M | $13.1M | 0.3% | $16.82 | -83.24% | 27 qtrssince 2019-Q1 | Unchanged 0 |
MAZE THERAPEUTICS INC | 457,535 | $11.9M | 0.3% | $11.42 | +120.67% | 3 qtrssince 2025-Q1 | Unchanged 0 |
AGORA INC | 2.1M | $8M | 0.2% | $4.20 | -9.52% | 4 qtrssince 2024-Q4 | Unchanged 0 |
CONTINEUM THERAPEUTICS INC | 669,337 | $7.9M | 0.2% | $17.61 | -32.88% | 6 qtrssince 2024-Q2 | Unchanged 0 |
HHLR ADVISORS, LTD. manages $4.1B across 33 positions as of Q3 2025. Top holdings: PDD (27.8%), BABA (14.4%), FUTU (13.8%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 2/5.0.
Active quarter - 5 new positions, 8 exits, 4 increased. Top move: BABA (INCREASED, conviction 100). Portfolio: $4.1B across 33 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
No active accumulation streaks detected for this filer.
Streaks require 2+ consecutive quarters of increased positions in the most recent period.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer